The strategy to maximise 1 dose initially is probably a win, so long as 1 dose efficacy is above 50% - which the limited data suggests it is, then it will protect more people faster than the 2 dose regimen going to half the amount of people. The mixing of different vaccines is less clear, but more of a worst case scenario anyway, the intention is to give people two of the same vaccine.